Lisa Boselli

1.3k total citations
13 papers, 383 citations indexed

About

Lisa Boselli is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Boselli has authored 13 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Boselli's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Lisa Boselli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Lisa Boselli collaborates with scholars based in France, Spain and Italy. Lisa Boselli's co-authors include Lydie Cassard, Nathalie Chaput, Jonathan Grivel, Marie Naigeon, Clélia Coutzac, Jean‐Yves Scoazec, Benjamin Besse, David Planchard, Boris Duchemann and Mélinda Charrier and has published in prestigious journals such as The Journal of Immunology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Lisa Boselli

13 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Boselli France 10 281 154 83 72 55 13 383
Matilde Monti Italy 10 212 0.8× 136 0.9× 48 0.6× 69 1.0× 126 2.3× 13 365
Stefania Laurent Italy 7 322 1.1× 284 1.8× 43 0.5× 65 0.9× 23 0.4× 10 448
Nooshin Hashemi Sadraei United States 10 199 0.7× 60 0.4× 66 0.8× 130 1.8× 63 1.1× 30 321
Grégoire Berthod Switzerland 10 298 1.1× 123 0.8× 95 1.1× 119 1.7× 19 0.3× 24 433
Galam Leem South Korea 11 166 0.6× 107 0.7× 50 0.6× 67 0.9× 41 0.7× 23 321
Giuseppe Cipollone Italy 7 220 0.8× 287 1.9× 68 0.8× 57 0.8× 12 0.2× 15 404
Kieran Adam United States 11 195 0.7× 191 1.2× 37 0.4× 73 1.0× 19 0.3× 26 350
Donald Gravenor United States 9 214 0.8× 174 1.1× 52 0.6× 150 2.1× 16 0.3× 24 433
Manik Uppal United States 5 188 0.7× 71 0.5× 147 1.8× 47 0.7× 31 0.6× 11 304
Mary McCauley United States 7 129 0.5× 97 0.6× 58 0.7× 60 0.8× 59 1.1× 13 306

Countries citing papers authored by Lisa Boselli

Since Specialization
Citations

This map shows the geographic impact of Lisa Boselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Boselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Boselli more than expected).

Fields of papers citing papers by Lisa Boselli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Boselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Boselli. The network helps show where Lisa Boselli may publish in the future.

Co-authorship network of co-authors of Lisa Boselli

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Boselli. A scholar is included among the top collaborators of Lisa Boselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Boselli. Lisa Boselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Flippot, Ronan, Marcus de Melo Teixeira, Lucía Carril-Ajuria, et al.. (2024). B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 12(4). e008636–e008636. 13 indexed citations
2.
Duchemann, Boris, Marie Naigeon, Édouard Auclin, et al.. (2022). CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. Journal for ImmunoTherapy of Cancer. 10(2). e004012–e004012. 21 indexed citations
3.
4.
Duchemann, Boris, Jordi Remón, Marie Naigeon, et al.. (2021). Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer. Translational Lung Cancer Research. 10(6). 2937–2954. 21 indexed citations
5.
Riudavets, Mariona, Marie Naigeon, Matthieu Texier, et al.. (2021). Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial. Lung Cancer. 166. 255–264. 15 indexed citations
6.
Duchemann, Boris, Jordi Remón, Marie Naigeon, et al.. (2020). Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer. Cancers. 12(12). 3625–3625. 28 indexed citations
7.
Mezquita, Laura, Patricia Martín-Romano, Édouard Auclin, et al.. (2019). MA07.01 Circulating Immature Neutrophils, Tumor-Associated Neutrophils and dNLR for Identification of Fast Progressors to Immunotherapy in NSCLC. Journal of Thoracic Oncology. 14(10). S272–S273. 3 indexed citations
8.
Charrier, Mélinda, Laura Mezquita, B. Lueza, et al.. (2019). Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. European Journal of Cancer. 108. 88–96. 34 indexed citations
9.
10.
Ferrara, Roberto, Marie Naigeon, Édouard Auclin, et al.. (2018). Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO). Annals of Oncology. 29. viii511–viii511. 7 indexed citations
11.
Pitoiset, Fabien, Lydie Cassard, Karim El Soufi, et al.. (2018). Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses. Cytometry Part A. 93(8). 793–802. 38 indexed citations
12.
Coutzac, Clélia, Julien Adam, Émilie Soularue, et al.. (2017). Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities. Journal of Crohn s and Colitis. 11(10). 1238–1246. 114 indexed citations
13.
Desbois, Mélanie, Clélia Coutzac, Elie Marcheteau, et al.. (2016). IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists. The Journal of Immunology. 197(1). 168–178. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matilde Monti Breakdown of academic impact, for papers by Stefania Laurent Breakdown of academic impact, for papers by Nooshin Hashemi Sadraei Breakdown of academic impact, for papers by Grégoire Berthod Breakdown of academic impact, for papers by Galam Leem Breakdown of academic impact, for papers by Giuseppe Cipollone Breakdown of academic impact, for papers by Kieran Adam Breakdown of academic impact, for papers by Donald Gravenor Breakdown of academic impact, for papers by Manik Uppal Breakdown of academic impact, for papers by Mary McCauley
Rankless by CCL
2026